U.S. FDA Warns of Risks With Compounded Topical Finasteride Products
The U.S Food and Drug Administration (FDA) is sounding the alarm about adverse events involving compounded topical finasteride products.
Category: Headlines in Dermatology
The U.S Food and Drug Administration (FDA) is sounding the alarm about adverse events involving compounded topical finasteride products.